SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ:CYTX) received U.S. Patent No. 7,501,115 (the ‘115 patent), which covers methods of cooling and cryopreserving stem and regenerative cells processed by the Celution® System. This patent provides additional protection for the Company’s cell banking platform, the StemSource® Cell Bank, which Cytori is currently commercializing in both Europe and Asia.
